MOLECULAR PROFILING OF PRIMARY BONE LYMPHOMAʼS REVEALS FREQUENT MUTATIONS IN EZH2 AND OTHER EPIGENETIC GENES: IMPLICATIONS FOR TARGETED TREATMENT: PF519